Universal germline genetic testing in sarcoma patients led to the identification of 8.7% of PGV with high or moderate penetrance genes including BRCA1, SDHA, TP53, ATM, NBN, RAD50, and DIS3L2 (Figure 1). The gene discussed is SDHA; the disease is sarcoma.